COMIRNATY JN.1 émuls inj 30 mcg/dose vial 10 pce

7680699120017 CH-69912 J07BN01 08.08.
COMIRNATY JN.1 émuls inj 30 mcg/dose vial 10 pce
COMIRNATY JN.1 émuls inj 30 mcg/dose vial 10 pce
COMIRNATY JN.1 émuls inj 30 mcg/dose vial 10 pce
1 / 3
google

Details

Product number
6991201
CPT
-
Packaging group
10
Unit
Durchstechflasche(n)
Composition
Suspension: bretovameranum 1 Dosis à 0.3 ml 30 µg pro dosi, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas), 2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, saccharum, trometamolum, trometamoli hydrochloridum, aqua ad iniectabile, 1 ml corresp..

Articles (1)

Comirnaty JN.1 30 μg, Injektionsdispersion
Injektionsdispersion
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
11/07/2025
Professional SmPC
Français
11/07/2025
Professional SmPC
Italien
11/07/2025
Patient information leaflet
Allemand
07/06/2025
Patient information leaflet
Français
07/06/2025
Patient information leaflet
Italien
07/06/2025

Detailed composition

Substance Quantity Type Category
SUS
30.0 UG Substance Wirkstoff (Principe actif)
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69912
Drug name
Comirnaty JN.1, Injektionsdispersion
Galenic form
DISIJ
ATC Code
J07BN01
Authorization status
Z
Dispensation category
B
First authorization
12/08/2024
Authorization expiration date
11/08/2029
IT number
08.08.
Domain
Human medicine

Packaging details

Description (FR)
COMIRNATY JN.1 émuls inj 30 mcg/dose vial 10 pce
Description (DE)
COMIRNATY JN.1 Inj Emuls 30 mcg/Dosis Vial 10 Stk
Market launch
21/08/2024
Narcotic (BTM)
No

Other packaging sizes

COMIRNATY JN.1 émuls inj 10 mcg/dose vial 10 pce
10 DUR
View